Search Results - "Mather, Cheryl A"

Comparison of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Systems for Identification of Mycobacteria Using Simplified Protein Extraction Protocols by Mather, Cheryl A, Rivera, Sheila F, Butler-Wu, Susan M

“…Classifications Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Rapid Detection of Vancomycin-Intermediate Staphylococcus aureus by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry by Mather, Cheryl A, Werth, Brian J, Sivagnanam, Shobini, SenGupta, Dhruba J, Butler-Wu, Susan M

“…Vancomycin is the standard of care for the treatment of invasive methicillin-resistantStaphylococcus aureus(MRSA) infections. Infections with…”
Get full text

CADD score has limited clinical validity for the identification of pathogenic variants in noncoding regions in a hereditary cancer panel by Mather, Cheryl A., Mooney, Sean D., Salipante, Stephen J., Scroggins, Sheena, Wu, David, Pritchard, Colin C., Shirts, Brian H.

“…Several in silico tools have been shown to have reasonable research sensitivity and specificity for classifying sequence variants in coding regions. The…”
Get full text

Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer by Ionescu, Diana N, Stockley, Tracy L, Banerji, Shantanu, Couture, Christian, Mather, Cheryl A, Xu, Zhaolin, Blais, Normand, Cheema, Parneet K, Chu, Quincy S-C, Melosky, Barbara, Leighl, Natasha B

“…Non-small cell lung cancer (NSCLC) has historically been associated with a poor prognosis and low 5-year survival, but the use of targeted therapies in NSCLC…”
Get full text

The impact of population-based EGFR testing in non-squamous metastatic non-small cell lung cancer in Alberta, Canada by Brenner, Darren R., O'Sullivan, Dylan E., Jarada, Tamer N., Yusuf, Amman, Boyne, Devon J., Mather, Cheryl A., Box, Adrian, Morris, Donald G., Cheung, Winson Y., Mirza, Imran

“…•We examined outcomes among NSCLC patients for an entire province over twenty years.•>80 % of eligible patients in Alberta who receive care for NSCLC are…”
Get full text

False positive cell free DNA screening for microdeletions due to non-pathogenic copy number variants by Mather, Cheryl A., Qi, Zhongxia, Wiita, Arun P.

“…What's Already Known about This Topic? Aneuploidy screening using cell free DNA (cfDNA) has recently been expanded to include selected microdeletions. However,…”
Get full text

The impact of population-based EGFR testing in metastatic non-small cell lung cancer in Alberta by Brenner, Darren R, O'Sullivan, Dylan E., Jarada, Tamer N., Yusuf, Amman, Boyne, Devon J, Mather, Cheryl A, Box, Adrian, Morris, Donald, Cheung, Winson Y., Mirza, Imran

“…e21139 Background: While Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors have been shown to be effective in phase III randomized trials, the…”
Get full text

CADD score has limited clinical validity for the identification of pathogenic variants in non-coding regions in a hereditary cancer panel by Mather, Cheryl A, Mooney, Sean D, Salipante, Stephen J, Scroggins, Sheena, Wu, David, Pritchard, Colin C, Shirts, Brian H

Get full text